Review History


All reviews of published articles are made public. This includes manuscript files, peer review comments, author rebuttals and revised materials. Note: This was optional for articles submitted before 13 February 2023.

Peer reviewers are encouraged (but not required) to provide their names to the authors when submitting their peer review. If they agree to provide their name, then their personal profile page will reflect a public acknowledgment that they performed a review (even if the article is rejected). If the article is accepted, then reviewers who provided their name will be associated with the article itself.

View examples of open peer review.

Summary

  • The initial submission of this article was received on December 6th, 2014 and was peer-reviewed by 2 reviewers and the Academic Editor.
  • The Academic Editor made their initial decision on December 21st, 2014.
  • The first revision was submitted on January 15th, 2015 and was reviewed by the Academic Editor.
  • The article was Accepted by the Academic Editor on January 18th, 2015.

Version 0.2 (accepted)

· Jan 18, 2015 · Academic Editor

Accept

The authors have carefully addressed reviewers question and revised the manuscript according by adding new data and discussion. This work is important to show that a CMKLR1 agonist might improve glucose homeostasis by increasing insulin-stimulated glucose uptake by adipocytes and would be of benefit in the treatment of type 2 diabetes associated with obesity.

Version 0.1 (original submission)

· Dec 21, 2014 · Academic Editor

Major Revisions

Both reviewers feel this work is of interest, however, more explanation on the "chemerin pathway" and a concise presentation are desired.

Reviewer 1 ·

Basic reporting

No Comments

Experimental design

It is important to perform the following experiments.
1. Compare the plasma chemerin level in wild-type, CMKLR1 knockout, and heterozygote mice.
2. Determine whether murine chemerin and some C-terminal peptides would decrease the high fat diet-induced obesity as well as glucose intolerance, through CMKLR1 or not.

Validity of the findings

Without showing the data mentioned above, the conclusion of this study is remarkably weakened. Please consider to supplement the manuscript with these data.

Additional comments

This study addresses an interesting and important question. Knockout mouse models used in this study are valuable. The authors are encouraged to provide more explanation and insights on the regulation of the "chemerin pathway" therapeutically. Specifically, is it on the level of agonists or the expression of chemerin receptor?

Reviewer 2 ·

Basic reporting

No Comments

Experimental design

Experimental designed include too many conditions with superficial observation, which made this study without a clear focus and deep mechanistic insight.

Validity of the findings

No Comments

Additional comments

There were hug data, but the associations of chemerin with studied conditions were not very excited since almost of measurements were mildly changed.

All text and materials provided via this peer-review history page are made available under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.